| Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors D Miao, CA Margolis, NI Vokes, D Liu, A Taylor-Weiner, SM Wankowicz, ... Nature genetics 50 (9), 1271-1281, 2018 | 435 | 2018 |
| Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids RW Jenkins, AR Aref, PH Lizotte, E Ivanova, S Stinson, CW Zhou, ... Cancer discovery 8 (2), 196-215, 2018 | 381 | 2018 |
| Response and acquired resistance to everolimus in anaplastic thyroid cancer N Wagle, BC Grabiner, EM Van Allen, A Amin-Mansour, A Taylor-Weiner, ... New England Journal of Medicine 371 (15), 1426-1433, 2014 | 330 | 2014 |
| Genomic analysis of metastatic cutaneous squamous cell carcinoma YY Li, GJ Hanna, AC Laga, RI Haddad, JH Lorch, PS Hammerman Clinical cancer research 21 (6), 1447-1456, 2015 | 259 | 2015 |
| Frameshift events predict anti–PD-1/L1 response in head and neck cancer GJ Hanna, P Lizotte, M Cavanaugh, FC Kuo, P Shivdasani, A Frieden, ... JCI insight 3 (4), 2018 | 206 | 2018 |
| Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus–unrelated head and neck cancer: a multicenter, phase II trial R Uppaluri, KM Campbell, AM Egloff, P Zolkind, ZL Skidmore, ... Clinical Cancer Research 26 (19), 5140-5152, 2020 | 179 | 2020 |
| Neoadjuvant nivolumab or nivolumab plus ipilimumab in untreated oral cavity squamous cell carcinoma: a phase 2 open-label randomized clinical trial JD Schoenfeld, GJ Hanna, VY Jo, B Rawal, YH Chen, PS Catalano, ... JAMA oncology 6 (10), 1563-1570, 2020 | 178 | 2020 |
| Incidence and demographic burden of HPV-associated oropharyngeal head and neck cancers in the United States BA Mahal, PJ Catalano, RI Haddad, GJ Hanna, JI Kass, JD Schoenfeld, ... Cancer epidemiology, biomarkers & prevention 28 (10), 1660-1667, 2019 | 134 | 2019 |
| Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions ML Cheng, E Pectasides, GJ Hanna, HA Parsons, AD Choudhury, ... CA: a cancer journal for clinicians 71 (2), 176-190, 2021 | 104 | 2021 |
| Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer GJ Hanna, JG Supplee, Y Kuang, U Mahmood, CJ Lau, RI Haddad, ... Annals of Oncology 29 (9), 1980-1986, 2018 | 99 | 2018 |
| Genomic correlates of response to everolimus in aggressive radioiodine-refractory thyroid cancer: a phase II study GJ Hanna, NL Busaidy, NG Chau, LJ Wirth, JA Barletta, A Calles, ... Clinical cancer research 24 (7), 1546-1553, 2018 | 91 | 2018 |
| The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana‐Farber/Brigham and Women’s Cancer Center multidisciplinary guideline A Sultan, GJ Hanna, DN Margalit, N Chau, LA Goguen, FM Marty, ... The Oncologist 22 (3), 343-350, 2017 | 82 | 2017 |
| A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant N Murakami, P Mulvaney, M Danesh, A Abudayyeh, A Diab, ... Kidney international 100 (1), 196-205, 2021 | 81 | 2021 |
| CIC‐NUTM1 fusion: A case which expands the spectrum of NUT‐rearranged epithelioid malignancies IM Schaefer, P Dal Cin, LM Landry, CDM Fletcher, GJ Hanna, CA French Genes, Chromosomes and Cancer 57 (9), 446-451, 2018 | 56 | 2018 |
| First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study SP D'Angelo, C Lebbé, L Mortier, AS Brohl, N Fazio, JJ Grob, N Prinzi, ... Journal for immunotherapy of cancer 9 (7), 2021 | 52 | 2021 |
| Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma GJ Hanna, SB Woo, YY Li, JA Barletta, PS Hammerman, JH Lorch International journal of oral and maxillofacial surgery 47 (5), 568-577, 2018 | 52 | 2018 |
| A randomized phase 2 study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma U Mahmood, A Bang, YH Chen, RH Mak, JH Lorch, GJ Hanna, M Nishino, ... International Journal of Radiation Oncology* Biology* Physics 109 (1), 134-144, 2021 | 49 | 2021 |
| Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck GJ Hanna, H Liu, RE Jones, AF Bacay, PH Lizotte, EV Ivanova, ... Oral oncology 67, 61-69, 2017 | 46 | 2017 |
| Neoadjuvant and adjuvant nivolumab and lirilumab in patients with recurrent, resectable squamous cell carcinoma of the head and neck GJ Hanna, A O'Neill, KY Shin, K Wong, VY Jo, CT Quinn, JM Cutler, ... Clinical Cancer Research 28 (3), 468-478, 2022 | 42 | 2022 |
| Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI) GJ Hanna, ES Ruiz, NR LeBoeuf, M Thakuria, CD Schmults, JA Decaprio, ... British Journal of Cancer 123 (10), 1535-1542, 2020 | 41 | 2020 |
